BUZZ-2,000 万美元直接股票交易后，Tonix 制药公司股价上涨

路透中文

Dec 29, 2025

BUZZ-2,000 万美元直接股票交易后，Tonix 制药公司股价上涨

12月29日 - ** 制药商Tonix Pharmaceuticals的TNXP.O股价盘前上涨0.9%至16.40美元

* (link) * TNXP宣布向史蒂文-科恩（Steven Cohen）的投资公司Point72注册直接发行2000万美元的普通股和预先筹资的认股权证。

** 发行价为每股 16.26 美元，与股票最后收盘价一致

** TD Cowen 担任发行的独家配售代理，A.G.P./Alliance Global Partners 担任财务顾问

** 募集资金将用于已上市产品的商业化、产品开发及其他用途

** 根据 LSEG 的数据，TNXP 拥有 1180 万股流通股，市值为 1.915 亿美元。

** 两家券商将其股票评级为 "买入"；PT 中值为 65 美元--数据由 LSEG 编制

** 截至上次收盘，TNXP股价累计下跌50.7

(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2595738684"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2595738684\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2595738684?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2025-12-29 21:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2595738684","market":"us","top_or_hot":-1,"title":"BUZZ-2,000 万美元直接股票交易后，Tonix 制药公司股价上涨","media":"路透中文","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-2,000 万美元直接股票交易后，Tonix 制药公司股价上涨</title></head><body><p><span>12月29日</span><span> - </span>** 制药商Tonix Pharmaceuticals的<span>TNXP.O</span>股价盘前上涨0.9%至16.40美元</p><p>* (link) * TNXP宣布向史蒂文-科恩（Steven Cohen）的投资公司Point72注册直接发行2000万美元的普通股和预先筹资的认股权证。</p><p>** 发行价为每股 16.26 美元，与股票最后收盘价一致</p><p>** TD Cowen 担任发行的独家配售代理，A.G.P./Alliance Global Partners 担任财务顾问</p><p>** 募集资金将用于已上市产品的商业化、产品开发及其他用途</p><p>** 根据 LSEG 的数据，TNXP 拥有 1180 万股流通股，市值为 1.915 亿美元。 </p><p>** 两家券商将其股票评级为 \"买入\"；PT 中值为 65 美元--数据由 LSEG 编制</p><p>** 截至上次收盘，TNXP股价累计下跌50.7</p><p>(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-2,000 万美元直接股票交易后，Tonix 制药公司股价上涨</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-2,000 万美元直接股票交易后，Tonix 制药公司股价上涨\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1098195322\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">路透中文 </p>\n<p class=\"h-time\">2025-12-29 21:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-2,000 万美元直接股票交易后，Tonix 制药公司股价上涨</title></head><body><p><span>12月29日</span><span> - </span>** 制药商Tonix Pharmaceuticals的<span>TNXP.O</span>股价盘前上涨0.9%至16.40美元</p><p>* (link) * TNXP宣布向史蒂文-科恩（Steven Cohen）的投资公司Point72注册直接发行2000万美元的普通股和预先筹资的认股权证。</p><p>** 发行价为每股 16.26 美元，与股票最后收盘价一致</p><p>** TD Cowen 担任发行的独家配售代理，A.G.P./Alliance Global Partners 担任财务顾问</p><p>** 募集资金将用于已上市产品的商业化、产品开发及其他用途</p><p>** 根据 LSEG 的数据，TNXP 拥有 1180 万股流通股，市值为 1.915 亿美元。 </p><p>** 两家券商将其股票评级为 \"买入\"；PT 中值为 65 美元--数据由 LSEG 编制</p><p>** 截至上次收盘，TNXP股价累计下跌50.7</p><p>(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nL4T3XZ0MC:1","article_id":"2595738684","we_media_id":"1098195322","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2595738684","pubTimestamp":1767014578,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"路透中文","introduction":"路透中文","home_visible":1,"id":"1098195322","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-2,000 万美元直接股票交易后，Tonix 制药公司股价上涨12月29日 - ** 制药商Tonix Pharmaceuticals的TNXP.O股价盘前上涨0.9%至16.40美元*  * TNXP宣布向史蒂文-科恩的投资公司Point72注册直接发行2000万美元的普通股和预先筹资的认股权证。** 发行价为每股 16.26 美元，与股票最后收盘价一致** TD Cowen 担任发行的独家配售代理，A.G.P./Alliance Global Partners 担任财务顾问** 募集资金将用于已上市产品的商业化、产品开发及其他用途** 根据 LSEG 的数据，TNXP 拥有 1180 万股流通股，市值为 1.915 亿美元。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","TNXP":"Tonix Pharmaceuticals Holding Co","BK4583":"猴痘概念"},"translate_title":"Tonix Pharmaceuticals Stock Rises After BUZZ-2 Million Direct Stock Deal","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TNXP":0.9},"content_text":"BUZZ-2,000 万美元直接股票交易后，Tonix 制药公司股价上涨12月29日 - ** 制药商Tonix Pharmaceuticals的TNXP.O股价盘前上涨0.9%至16.40美元* (link) * TNXP宣布向史蒂文-科恩（Steven Cohen）的投资公司Point72注册直接发行2000万美元的普通股和预先筹资的认股权证。** 发行价为每股 16.26 美元，与股票最后收盘价一致** TD Cowen 担任发行的独家配售代理，A.G.P./Alliance Global Partners 担任财务顾问** 募集资金将用于已上市产品的商业化、产品开发及其他用途** 根据 LSEG 的数据，TNXP 拥有 1180 万股流通股，市值为 1.915 亿美元。 ** 两家券商将其股票评级为 \"买入\"；PT 中值为 65 美元--数据由 LSEG 编制** 截至上次收盘，TNXP股价累计下跌50.7(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}